Form D · Biotechnology
OyaGen Inc.
Rochester, NY · CIK 0001319956
Offering snapshot reported Dec 12, 2017 · SEC filing
- Reported sold
- $345K Offering amount: $700K
- Investors reported
- 11 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Nov 29, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 12, 2017 | Initial | $345,000 | No comparison | 11 | SEC filing |
| Oct 11, 2012 | Initial | $1,742,315 | No comparison | 10 | SEC filing |
| Sep 17, 2009 | Amendment | $1,029,709 | No comparison | 12 | SEC filing |
| Sep 8, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Mar 1, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-300498
Source: Form D, filed Dec 12, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ryan Bennett | Executive |
| William Carpenter | Director |
| Jose Coronas | Director |
| Thomas Fitzgerald | Executive, Promoter |
| Richard Mc Closkey | Director |
| Roscoe Moore | Director |
| Richard Ogden | Director |
| Kevin Phelps | Director, Executive |
| Harold Smith | Director, Executive, Promoter |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
Rochester Bio Venture Center 77 Ridgeland Road
Rochester, NY, 14623
Rochester, NY, 14623